Connect with us

COVID-19

After COVID scare, UNILAG reopens campus for exams

Published

on

The University of Lagos (UNILAG) has asked its students to resume physically for second semester examinations, which will be held between August 26 and September 26, 2021.
The students were sent home six weeks ago to prevent spread of COVID-19 after a scare on the campus.
The students have been receiving online classes using the institution’s Learning Management System (LMS) since the July 12 closure.
But the institution said it had made a staggered arrangement for students with registered bed spaces to resume in the hostels from August 9, 2021.
Part of the statement read, ”The university has also approved the commencement of the second semester examinations to hold physically from Thursday, 26th August, 2021.
“The examinations will start with the General Studies (GST) Examinations scheduled to hold from Thursday, 26th August, 2021 to Saturday, 28th August, 2021.
“In order to ensure the safety of staff and students during this period, the University will adhere strictly to all COVID-19 protocols.
“Special arrangements have been made with the Lagos University Teaching Hospital (LUTH) and Gbagada General Hospital for necessary isolation and treatment of any incidence of COVID-19 case during the examinations.
“The university management has approved the schedule of accommodation of bonafide students with allocated bed spaces in the hostels for the second semester examinations as follows: 100 and 200 level students with allocated bed spaces should move into the hostels from Thursday, 26th August 2021 and depart on or before Saturday, 11th September 2021.
“500 level Faculty of Law Students with allocated bed spaces should move into their hostels on Saturday, 28th August 2021 and depart on Sunday, 5th September 2021.”

COVID-19

Kaduna gives civil servants 12-day ultimatum on COVID vaccine

Published

on

The Kaduna State Government has given all civil servants in the state 12 days to receive the COVID-19 vaccine or be barred from office.

The ultimatum was announced in a statement issued on Tuesday by Muyiwa Adekeye, spokesman for the state governor, Nasir el-Rufai.

According to him, all civil servants are expected to be vaccinated by October 31, after which they would be denied entry into government offices if they failed to comply with the directive.

“The Kaduna State Government will from 31st October 2021 require compliance with COVID-19 protocols, especially facemasks and vaccination, for access to its offices,” the statement said.

“The Ministry of Health has since commenced the vaccination of all civil servants, and this is expected to be completed by 31st October 2021. All civil servants are required to be vaccinated by that date.

“Visitors to government offices will need to present their vaccination cards. Given the limited supply of vaccines that are currently available, visitors that have not yet been vaccinated will, in the interim, be permitted entry upon presentation of evidence of registration with the state Ministry of Health for the purpose of vaccination, while wearing their facemasks.”

Adekeye said the decision was taken following a review by the Kaduna COVID-19 task force, and urged residents to ensure strict adherence to the protocol for preventing the spread of infections.

According to the statement, Amina Mohammed-Baloni, Kaduna commissioner for health, has also asked residents to register at the nearest primary health centres for vaccination “so that the relevant authorities can easily contact them as more Covid-19 vaccines become available”.

The development comes weeks after Edo began its ‘no vaccination, no entry’ campaign, which bars unvaccinated civil servants from entering government offices.

Continue Reading

COVID-19

Global COVID-19 Deaths Hit 5m As Delta Variant Rages

Published

on

Dr Emmanuel Ehanire

Worldwide deaths related to COVID-19 surpassed five million at the weekend, according to a Reuters tally, with unvaccinated people particularly exposed to the virulent Delta strain.
The variant has exposed the wide disparities in vaccination rates between rich and poor nations, and the upshot of vaccine hesitancy in some western nations.
More than half of all global deaths reported on a seven-day average were in the United States, Russia, Brazil, Mexico and India.
While it took just over a year for the COVID-19 death toll to hit 2.5 million, the next 2.5 million deaths were recorded in just under eight months, according to a Reuters analysis.
An average of 8,000 deaths were reported daily across the world over the last week, or around five deaths every minute. However, the global death rate has been slowing in recent weeks.
There has been increasing focus in recent days on getting vaccines to poorer nations, where many people are yet to receive a first dose, even as their richer counterparts have begun giving booster shots.
More than half of the world has yet to receive at least one dose of a COVID-19 vaccine, according to Our World in Data.
The World Health Organization this week said its COVAX distribution programme would, for the first time, distribute shots only to countries with the lowest levels of coverage.
Co-led by the WHO, COVAX has since January largely allocated doses proportionally among its 140-plus beneficiary states according to population size.
“For the October supply we designed a different methodology, only covering participants with low sources of supply,” Mariangela Simao, WHO Assistant Director General for Access to Vaccines, said in a recording of a conference presentation last week posted on the WHO’s website.
Leadership

Continue Reading

COVID-19

FG okays another COVID vaccine, Sinopharm, for Nigeria

Published

on

Another COVID-19 vaccine, Sinopharm BBIBP-CorV, has been approved for use in Nigeria, Executive Director, National Primary Health Care Development Agency, Faisal Shuaib, has said.

He stated this on Tuesday at a media briefing in Abuja.

The approval is coming some weeks after NAFDAC approved the Moderna and Sputnik V COVID-19 vaccines for emergency use in Nigeria.

The Sinopharm COVID-19 vaccine is an inactivated COVID-19 vaccine and had been approved by the World Health Organisation for emergency use.

Shuaib said on Tuesday that the National Agency for Food and Drug Administration and Control had approved the vaccine three days ago.

“NAFDAC has approved Sinopharm vaccine. The approval was done three days ago. And yes, Sinopharm vaccine has also received WHO certification,” he said.

He also said, “It is a potential vaccine that we could use. There are so many vaccines out there, but one thing that we are very clear about is that we are not going to use all the available vaccines in Nigeria.

“At some point, we are going to draw a line in terms of the number of vaccines we would use, so that we can keep a close watch on the number of vaccines we are utilising in Nigeria.”

He said the vaccine was developed by Sinopharm’s Beijing Institute of Biological Products, “sometimes written as Beijing Bio-Institute of Biological Products”, noting that there are sometimes two different acronyms, BBIBP and BIBP, for the same vaccine.

“It completed phase three trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru and United Arab Emirates (UAE), with over 60,000 participants. BBIBP-CorV shares, similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19,” he said.

“Its product name is SARS-CoV-2 Vaccine ‘Vero Cell’, not to be confused with the similar product name of CoronaVac,” Shuaib said.

Continue Reading

Trending